Opioid prescribing has been highly scrutinized in the US over the last 10 yrs. Yet, patients continue to present to primary care with complaints of pain. Opioids remain a cornerstone of treatment. This session will focus on how and when it is appropriate to prescribe opioids in primary care. | 1.50 credits (1.50 Pharmacology) | $40

Adolescent substance use has followed familiar trends for several decades with alcohol, nicotine, and cannabis leading other drugs in popularity. After several years of declining nicotine use, primarily via combustible cigarettes, recent data suggests a resurgence of nicotine use, primarily via e-cigarettes as well as a marked increase in cannabis use, likely corresponding with legalization efforts. Additionally, there has been an increase in hallucinogen use and the dangers of opioid use have heightened due to the rise of illicit fentanyl being brought in from outside the United States. This lecture will review the most recent Monitoring the Future study and discuss implications of adolescent substance use trends on healthcare providers. | 1.50 credits (1.50 Pharmacology) | $40

During the last 20 years, the rules and regulations regarding pain, opioid prescribing and opioid use disorder have changed significantly. Attendees will be taught the latest and most up-to-date information on DEA’s authority and background, licensing, registration, drug diversion, telemedicine, medication assistance treatment, nationwide opioid prescribing guidelines and case studies, along with learning risk mitigation strategies and best practices that will safeguard their practices. The instructor is a former DEA Special Agent with over 30 years of public service with real life prescription opioid experience. | 1.50 credits (1.00 Pharmacology) | $40